Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Patient Preference × Injections, Subcutaneous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1 Patient Preference 1 Inflammatory Breast Neoplasms 1 Abdominal Cancer 1

Interventions

pertuzumab 1 pazopanib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1 apalutamide 1 Trastuzumab 1 Surgical Procedures, Operative 1 Sunitinib 1 Radiotherapy 1 Injections, Subcutaneous 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05415215 2026-02-10

ProHer

Hoffmann-La Roche

Phase 3 Completed

346 enrolled 20 charts

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡